(Q36987080)

17 August 2017

1 reference

title

Quality of life of patients with ulcerative colitis: past, present, and future (English)

1 reference

17 August 2017

1 reference

E Jan Irvine

1

1 reference

17 August 2017

publication date

1 April 2008

1 reference

Inflammatory Bowel Diseases

17 August 2017

published in

1 reference

17 August 2017

volume

14

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

554-565

1 reference

The epidemiology of inflammatory bowel disease in Canada: a population-based study

17 August 2017

cites work

1 reference

Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000.

21 January 2018

1 reference

Determinants of life satisfaction in inflammatory bowel disease.

21 January 2018

1 reference

Questions on life satisfaction (FLZM) in inflammatory bowel disease

21 January 2018

1 reference

21 January 2018

1 reference

Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life

21 January 2018

1 reference

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

Quality of life measurement in gastrointestinal and liver disorders

21 January 2018

1 reference

Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, Greece

21 January 2018

1 reference

21 January 2018

1 reference

Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study.

21 January 2018

1 reference

Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis

21 January 2018

1 reference

Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis.

21 January 2018

1 reference

Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the Inflammatory Bowel Disease Questionnaire.

21 January 2018

1 reference

Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ.

21 January 2018

1 reference

21 January 2018

1 reference

Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis.

21 January 2018

1 reference

Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire.

21 January 2018

1 reference

The UK IBDQ-a British version of the inflammatory bowel disease questionnaire. development and validation.

21 January 2018

1 reference

The inflammatory bowel disease questionnaire: a review of its national validation studies

21 January 2018

1 reference

[Quality of life in patients with inflammatory bowel diseases: translation to Portuguese language and validation of the "Inflammatory Bowel Disease Questionnaire" (IBDQ)].

21 January 2018

1 reference

Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease

21 January 2018

1 reference

Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II.

21 January 2018

1 reference

Predictors of quality of life in ulcerative colitis: the importance of symptoms and illness representations.

21 January 2018

1 reference

The correlation between quality of life and functional outcome in ulcerative colitis patients after proctocolectomy ileal pouch anal anastomosis

21 January 2018

1 reference

Prospective assessment of Cleveland Global Quality of Life (CGQL) as a novel marker of quality of life and disease activity in Crohn's disease

21 January 2018

1 reference

Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.

21 January 2018

1 reference

Heightened responses to stressors in patients with inflammatory bowel disease

21 January 2018

1 reference

Psychological stress in IBD: new insights into pathogenic and therapeutic implications

21 January 2018

1 reference

Effect of oral tacrolimus (FK 506) on steroid-refractory moderate/severe ulcerative colitis

21 January 2018

1 reference

Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis

21 January 2018

1 reference

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

21 January 2018

1 reference

A new oral delivery system for 5-ASA: preliminary clinical findings for MMx.

21 January 2018

1 reference

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis

21 January 2018

1 reference

Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease

21 January 2018

1 reference

Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters

21 January 2018

1 reference

A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis

21 January 2018

1 reference

Compliance with treatment regimens in chronic asymptomatic diseases

21 January 2018

1 reference

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis

21 January 2018

1 reference

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

21 January 2018

1 reference

An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis

21 January 2018

1 reference

A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis

21 January 2018

1 reference

Systematic review: adherence issues in the treatment of ulcerative colitis

21 January 2018

1 reference

Infliximab improves quality of life in patients with Crohn's disease

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

Review article: Infliximab therapy for inflammatory bowel disease--seven years on

21 January 2018

1 reference

21 January 2018

1 reference

Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis

21 January 2018

1 reference

Quality of life after restorative proctocolectomy with a pelvic ileal reservoir compares favorably with that of patients with medically treated colitis

21 January 2018

1 reference

Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis

21 January 2018

1 reference

A cluster-randomised controlled trial of a patient-centred guidebook for patients with ulcerative colitis: effect on knowledge, anxiety and quality of life.

21 January 2018

1 reference

A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis

21 January 2018

1 reference

Guided self-management and patient-directed follow-up of ulcerative colitis: a randomised trial

21 January 2018

1 reference

Hand-assisted laparoscopic versus open restorative proctocolectomy with ileal pouch anal anastomosis: a randomized trial

21 January 2018

1 reference

Randomized prospective trial comparing ileal pouch-anal anastomosis performed by excising the anal mucosa to ileal pouch-anal anastomosis performed by preserving the anal mucosa.

21 January 2018

1 reference

Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial

21 January 2018

1 reference

The optimal dose of 5-aminosalicylic acid in active ulcerative colitis: a dose-finding study with newly developed mesalamine

21 January 2018

1 reference

Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial

21 January 2018

1 reference

Inflammatory bowel disease: clinical aspects and established and evolving therapies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20301

1 reference

release_eudpqsw3rve6lfkoexlachchiq

17 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eudpqsw3rve6lfkoexlachchiq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference